The controlled-release oxycodone tablet formulation (OCRT) was approved in China in 2004 for management of moderate to severe cancer pain. Few data about the efficacy of OCRT and clinical outcomes ...

Johnson & Johnson has been given FDA approval for Akeega, a combination tablet for first-line treatment of adults with BRCA-positive metastatic castration-resistant prostate cancer (mCRPC).

Background and objectives: Patients with cancer, particularly those undergoing ... investigate the absorption profile of fentanyl buccal tablet (FBT) -- an effervescent formulation of fentanyl ...